A Survey of the Neuro-Oncology Landscape

Rimas V Lukas1, Jing Wu2, Mahua Dey3

  • 1Department of Neurology, Northwestern University, Chicago, IL, USA. rimas.lukas@nm.org.

Insights

Neuro-oncology is rapidly advancing, particularly for high-grade gliomas and brain metastases. This overview highlights key recent medical and surgical breakthroughs impacting patient care.

Area of Science:

  • Neuroscience
  • Oncology
  • Clinical Medicine

Background:

  • The field of neuro-oncology is experiencing rapid evolution.
  • Significant recent advances and promising investigations are emerging, particularly for high-grade gliomas and brain metastases.

Purpose of the Study:

  • To provide an overview of the current status of neuro-oncology.
  • To highlight key recent advances and ongoing clinical investigations.
  • To offer a timely understanding of the field's dynamic changes and future directions.

Main Methods:

  • Review of recent scientific literature and clinical investigations.
  • Inclusion of work presented in abstract form for timely insights.
  • Focus on both medical and surgical neuro-oncology advancements.

Main Results:

  • Identification of key recent advances in neuro-oncology.
  • Highlighting of promising clinical investigations with potential impact.
  • Emphasis on multidisciplinary approaches in neuro-oncology.

Conclusions:

  • Neuro-oncology is rapidly advancing, with significant potential impact on clinical management.
  • Ongoing research in high-grade gliomas and brain metastases is crucial.
  • A multidisciplinary approach is essential for progress in neuro-oncology.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.6K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.9K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K